Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as needle exchange and opiate substitution therapy (OST) alone. Current HCV treatment is arduous and uptake is low, but new highly effective and t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Martin, Natasha K, Vickerman, Peter, Grebely, Jason, Hellard, Margaret, Hutchinson, Sharon J, Lima, Viviane D, Foster, Graham R, Dillon, John F, Goldberg, David J, Dore, Gregory J, Hickman, Matthew
Format: Artigo
Langue:Inglês
Publié: Blackwell publishing Ltd 2013
Sujets:
Viral Hepatitis
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3933734/
https://ncbi.nlm.nih.gov/pubmed/23553643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.26431
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires